These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32486916)

  • 1. Active and prospective latent tuberculosis are associated with different metabolomic profiles: clinical potential for the identification of rapid and non-invasive biomarkers.
    Albors-Vaquer A; Rizvi A; Matzapetakis M; Lamosa P; Coelho AV; Patel AB; Mande SC; Gaddam S; Pineda-Lucena A; Banerjee S; Puchades-Carrasco L
    Emerg Microbes Infect; 2020 Dec; 9(1):1131-1139. PubMed ID: 32486916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis-associated metabolites that distinguish active pulmonary tuberculosis in humans.
    Collins JM; Walker DI; Jones DP; Tukvadze N; Liu KH; Tran VT; Uppal K; Frediani JK; Easley KA; Shenvi N; Khadka M; Ortlund EA; Kempker RR; Blumberg HM; Ziegler TR
    PLoS One; 2018; 13(10):e0205398. PubMed ID: 30308073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma heme oxygenase-1 levels distinguish latent or successfully treated human tuberculosis from active disease.
    Andrade BB; Pavan Kumar N; Mayer-Barber KD; Barber DL; Sridhar R; Rekha VV; Jawahar MS; Nutman TB; Sher A; Babu S
    PLoS One; 2013; 8(5):e62618. PubMed ID: 23671613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of antigen-specific memory and regulatory T-cell subsets differentiate latent and active tuberculosis.
    Pathakumari B; Devasundaram S; Raja A
    Immunology; 2018 Mar; 153(3):325-336. PubMed ID: 28881482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of GM-CSF and IL-2 in response to long-term specific-antigen cell stimulation in patients with active and latent tuberculosis infection.
    Balcells ME; Ruiz-Tagle C; Tiznado C; García P; Naves R
    Tuberculosis (Edinb); 2018 Sep; 112():110-119. PubMed ID: 30205963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of candidate host serum and saliva biomarkers for a better diagnosis of active and latent tuberculosis infection.
    Estévez O; Anibarro L; Garet E; Pallares Á; Pena A; Villaverde C; Del Campo V; González-Fernández Á
    PLoS One; 2020; 15(7):e0235859. PubMed ID: 32687494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray-based selection of a serum biomarker panel that can discriminate between latent and active pulmonary TB.
    Li Z; Hu J; Liu P; Cui D; Di H; Wu S
    Sci Rep; 2021 Jul; 11(1):14516. PubMed ID: 34267288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted metabolomics analysis of serum and Mycobacterium tuberculosis antigen-stimulated blood cultures of pediatric patients with active and latent tuberculosis.
    Magdalena D; Michal S; Marta S; Magdalena KP; Anna P; Magdalena G; Rafał S
    Sci Rep; 2022 Mar; 12(1):4131. PubMed ID: 35260782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PpiA antigen specific immune response is a potential biomarker for latent tuberculosis infection.
    Pathakumari B; Anbarasu D; Parthasarathy RT; Raja A
    Tuberculosis (Edinb); 2015 Dec; 95(6):736-743. PubMed ID: 26546406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma metabolomics in human pulmonary tuberculosis disease: a pilot study.
    Frediani JK; Jones DP; Tukvadze N; Uppal K; Sanikidze E; Kipiani M; Tran VT; Hebbar G; Walker DI; Kempker RR; Kurani SS; Colas RA; Dalli J; Tangpricha V; Serhan CN; Blumberg HM; Ziegler TR
    PLoS One; 2014; 9(10):e108854. PubMed ID: 25329995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between DNA Methylation Profiles and Active Tuberculosis Development from Latent Infection: a Pilot Study in Nested Case-Control Design.
    Du Y; Gao X; Yan J; Zhang H; Cao X; Feng B; He Y; He Y; Guo T; Xin H; Gao L
    Microbiol Spectr; 2022 Jun; 10(3):e0058622. PubMed ID: 35446152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron homeostasis and progression to pulmonary tuberculosis disease among household contacts.
    Minchella PA; Donkor S; McDermid JM; Sutherland JS
    Tuberculosis (Edinb); 2015 May; 95(3):288-93. PubMed ID: 25764944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of interleukin-2 is not useful for distinguishing between latent and active tuberculosis in clinical practice: a prospective cohort study.
    Santin M; Morandeira-Rego F; Alcaide F; Rabuñal R; Anibarro L; Agüero-Balbín R; Casas-Garcia X; Pérez-Escolano E; Navarro MD; Sánchez F; Coira-Nieto A; Trigo-Daporta M; Martinez-Meñaca A; Gonzalez-Cuevas A; López-Prieto MD; Domínguez-Castellano A; Jové N;
    Clin Microbiol Infect; 2016 Dec; 22(12):1007.e1-1007.e5. PubMed ID: 27647563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of serum biomarkers for active pulmonary tuberculosis using a targeted metabolomics approach.
    Cho Y; Park Y; Sim B; Kim J; Lee H; Cho SN; Kang YA; Lee SG
    Sci Rep; 2020 Mar; 10(1):3825. PubMed ID: 32123207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.
    Berry MP; Graham CM; McNab FW; Xu Z; Bloch SA; Oni T; Wilkinson KA; Banchereau R; Skinner J; Wilkinson RJ; Quinn C; Blankenship D; Dhawan R; Cush JJ; Mejias A; Ramilo O; Kon OM; Pascual V; Banchereau J; Chaussabel D; O'Garra A
    Nature; 2010 Aug; 466(7309):973-7. PubMed ID: 20725040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of interferon (IFN)-γ inducible protein 10 (IP-10) as a biomarker for the discrimination of active and latent tuberculosis.
    Mamishi S; Mahmoudi S; Banar M; Hosseinpour Sadeghi R; Marjani M; Pourakbari B
    Mol Biol Rep; 2019 Dec; 46(6):6263-6269. PubMed ID: 31564016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis.
    Lubbers R; Sutherland JS; Goletti D; de Paus RA; van Moorsel CHM; Veltkamp M; Vestjens SMT; Bos WJW; Petrone L; Del Nonno F; Bajema IM; Dijkman K; Verreck FAW; Walzl G; Gelderman KA; Groeneveld GH; Geluk A; Ottenhoff THM; Joosten SA; Trouw LA
    Front Immunol; 2018; 9():2427. PubMed ID: 30405622
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
    La Manna MP; Orlando V; Li Donni P; Sireci G; Di Carlo P; Cascio A; Dieli F; Caccamo N
    PLoS One; 2018; 13(3):e0192664. PubMed ID: 29543810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of active tuberculosis and latent tuberculosis infection based on Raman spectroscopy and surface-enhanced Raman spectroscopy.
    Kaewseekhao B; Nuntawong N; Eiamchai P; Roytrakul S; Reechaipichitkul W; Faksri K
    Tuberculosis (Edinb); 2020 Mar; 121():101916. PubMed ID: 32279876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-validation of existing signatures and derivation of a novel 29-gene transcriptomic signature predictive of progression to TB in a Brazilian cohort of household contacts of pulmonary TB.
    Leong S; Zhao Y; Ribeiro-Rodrigues R; Jones-López EC; Acuña-Villaorduña C; Rodrigues PM; Palaci M; Alland D; Dietze R; Ellner JJ; Johnson WE; Salgame P
    Tuberculosis (Edinb); 2020 Jan; 120():101898. PubMed ID: 32090859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.